Access the full text.
Sign up today, get DeepDyve free for 14 days.
Homa Boroumand, F. Badie, S. Mazaheri, Z. Seyedi, J. Nahand, M. Nejati, H. Baghi, Mohammad Abbasi-kolli, B. Badehnoosh, Maryam Ghandali, Michael Hamblin, H. Mirzaei (2021)
Chitosan-Based Nanoparticles Against Viral InfectionsFrontiers in Cellular and Infection Microbiology, 11
Rebeca Stiepel, Cole Batty, C. MacRaild, R. Norton, E. Bachelder, K. Ainslie (2020)
Merozoite Surface Protein 2 Adsorbed onto Acetalated Dextran Microparticles for Malaria Vaccination.International journal of pharmaceutics
Ruchi Shah, D. O’hagan, M. Amiji, Luis Brito (2014)
The impact of size on particulate vaccine adjuvants.Nanomedicine, 9 17
(2021)
10.1039/D1CC00811KChem. Commun., 57
Yumiko Ishii-Mizuno, Yuka Umeki, Y. Onuki, Hiroshi Watanabe, Yuki Takahashi, Y. Takakura, M. Nishikawa (2017)
Improved sustained release of antigen from immunostimulatory DNA hydrogel by electrostatic interaction with chitosan.International journal of pharmaceutics, 516 1-2
W. Tonnis, Maarten Mensink, A. Jager, K. Maarschalk, H. Frijlink, W. Hinrichs (2015)
Size and molecular flexibility of sugars determine the storage stability of freeze-dried proteins.Molecular pharmaceutics, 12 3
W. Houston, C. Crabbs, R. Kremer, J. Springer (1976)
Adjuvant effects of diethylaminoethyl-dextranInfection and Immunity, 13
Cuiling Zhang, Giulietta Maruggi, H. Shan, Junwei Li (2019)
Advances in mRNA Vaccines for Infectious DiseasesFrontiers in Immunology, 10
J. Jonge, Jean‐Pierre Amorij, W. Hinrichs, J. Wilschut, A. Huckriede, H. Frijlink (2007)
The development of stable influenza vaccine powder formulations for new needle-free dosage forms
Ashgan El-sissi, Farida Mohamed, N. Danial, Ali Gaballah, K. Ali (2020)
Chitosan and chitosan nanoparticles as adjuvant in local Rift Valley Fever inactivated vaccine3 Biotech, 10
Dharmendra Raghuwanshi, V. Mishra, D. Das, K. Kaur, M. Suresh (2012)
Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein.Molecular pharmaceutics, 9 4
D. Gordon, Peter Kelley, S. Heinzel, P. Cooper, N. Petrovsky (2014)
Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study.Vaccine, 32 48
(2008)
Bramwell
S. Reddy, M. Swartz, J. Hubbell (2006)
Targeting dendritic cells with biomaterials: developing the next generation of vaccines.Trends in immunology, 27 12
Christoph Franck, Luise Fanslau, Andrea Popov, P. Tyagi, L. Fruk (2020)
Biopolymer‐based Carriers for DNA Vaccine DesignAngewandte Chemie (International Ed. in English), 60
Kimberly Hassett, Natalie Meinerz, F. Semmelmann, Megan Cousins, R. Garcea, T. Randolph (2015)
Development of a highly thermostable, adjuvanted human papillomavirus vaccine.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 94
J Domachowske, J Domachowske, M Suryadevar (2021)
10.1007/978-3-030-58414-6_4Vaccines: A Clinical Overview and Practical Guide
Chuan-chang Chuang, Meng-hung Tsai, Hui-ju Yen, Huey-fen Shyu, Kuang-ming Cheng, Xin-an Chen, Cheng-cheung Chen, Jenn-jong Young, Jyh-hwa Kau (2020)
A fucoidan-quaternary chitosan nanoparticle adjuvant for anthrax vaccine as an alternative to CpG oligodeoxynucleotides.Carbohydrate polymers, 229
(World Health Organization. Guidelines on Stability Evaluation of Vaccines, Expert Committee on Biological Standardization, Technical Report Series 57th Report, Geneva, 2006, No. 962, Annex 3.)
World Health Organization. Guidelines on Stability Evaluation of Vaccines, Expert Committee on Biological Standardization, Technical Report Series 57th Report, Geneva, 2006, No. 962, Annex 3.World Health Organization. Guidelines on Stability Evaluation of Vaccines, Expert Committee on Biological Standardization, Technical Report Series 57th Report, Geneva, 2006, No. 962, Annex 3., World Health Organization. Guidelines on Stability Evaluation of Vaccines, Expert Committee on Biological Standardization, Technical Report Series 57th Report, Geneva, 2006, No. 962, Annex 3.
K. Joshy, A. George, S. Snigdha, B. Joseph, N. Kalarikkal, L. Pothen, Sabu Thomas (2018)
Novel core-shell dextran hybrid nanosystem for anti-viral drug delivery.Materials science & engineering. C, Materials for biological applications, 93
C. Alfano, D. Sanfelice, S. Martin, A. Pastore, P. Temussi (2017)
An optimized strategy to measure protein stability highlights differences between cold and hot unfolded statesNature Communications, 8
Pilar Garcia-Vello, Immacolata Speciale, F. Chiodo, A. Molinaro, C. Castro (2020)
Carbohydrate-based adjuvants.Drug discovery today. Technologies, 35-36
(2000)
10.1016/S0167-7799(00)01485-2Trends Biotechnol., 18
Carlo Pifferi, Roberto Fuentes, Alberto Fernández‐Tejada (2021)
Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of actionNature Reviews. Chemistry, 5
W. Tonnis, Jean‐Pierre Amorij, M. Vreeman, H. Frijlink, G. Kersten, W. Hinrichs (2014)
Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 55
L. Peek, Talia Martin, Charity Nation, Shannel Pegram, C. Middaugh (2007)
Effects of stabilizers on the destabilization of proteins upon adsorption to aluminum salt adjuvants.Journal of pharmaceutical sciences, 96 3
E. Passeri, C. Villa, M. Couette, E. Itti, P. Brugières, P. Césaro, R. Gherardi, A. Bachoud-Lévi, F. Authier (2011)
Long-term follow-up of cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF).Journal of inorganic biochemistry, 105 11
Shuang Yu, Shengnan Hao, Beini Sun, Dongying Zhao, Xingye Yan, Kai Zhao (2019)
Quaternized Chitosan Nanoparticles in Vaccine Applications.Current medicinal chemistry
P. Ma, M. Lavertu, F. Winnik, M. Buschmann (2009)
New insights into chitosan-DNA interactions using isothermal titration microcalorimetry.Biomacromolecules, 10 6
T. Nolan, P. Richmond, N. Formica, K. Höschler, M. Skeljo, Tanya Stoney, J. McVernon, G. Hartel, Daphne Sawlwin, J. Bennet, D. Ryan, R. Basser, M. Zambon (2008)
Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.Vaccine, 26 50
Harshad Harde, A. Agrawal, Sanyog Jain (2014)
Tetanus Toxoids Loaded Glucomannosylated Chitosan Based Nanohoming Vaccine Adjuvant with Improved Oral Stability and Immunostimulatory ResponsePharmaceutical Research, 32
Naveen Kanthamneni, Sadhana Sharma, Samantha Meenach, Beau Billet, Ji-Cheng Zhao, E. Bachelder, K. Ainslie (2012)
Enhanced stability of horseradish peroxidase encapsulated in acetalated dextran microparticles stored outside cold chain conditions.International journal of pharmaceutics, 431 1-2
F. Cardoso, D. Petrovajova, T. Horňáková (2017)
Viral vaccine stabilizers: status and trends.Acta virologica, 61 3
M. Ghalavand, M. Saadati, J. Salimian, E. Abbasi, G. Hosseinzadeh, Hadi Ghaleh, A. Ahmadi (2021)
Biological properties the novel application of N-trimethyl chitosan nanospheres as a stabilizer and preservative in tetanus vaccineClinical and Experimental Vaccine Research, 10
(S. Ausar, Hasija, Li, and Rahman, VDT, 11 (2013).)
S. Ausar, Hasija, Li, and Rahman, VDT, 11 (2013).S. Ausar, Hasija, Li, and Rahman, VDT, 11 (2013)., S. Ausar, Hasija, Li, and Rahman, VDT, 11 (2013).
V. Apostolopoulos (2010)
New Generation VaccinesExpert Review of Vaccines, 9
Ricardo Correia, Liane Meneses, Carolina Richheimer, P. Alves, M. Carrondo, A. Duarte, Alexandre Paiva, A. Roldão (2021)
Improved storage of influenza HA-VLPs using a trehalose-glycerol natural deep eutectic solvent system.Vaccine
J. Aguilar, E. Rodríguez (2007)
Vaccine adjuvants revisited.Vaccine, 25 19
(2016)
10.1172/JCI81083J. Clin. Investig., 126
A. Santos, G. Rocha, J. Andrade (2019)
Occurrence of the potent mutagens 2- nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particlesScientific Reports, 9
R. Kramer, Yuhong Zeng, N. Sahni, L. Kueltzo, Richard Schwartz, I. Srivastava, Lindsey Crane, S. Joshi, D. Volkin, C. Middaugh (2013)
Development of a stable virus-like particle vaccine formulation against Chikungunya virus and investigation of the effects of polyanions.Journal of pharmaceutical sciences, 102 12
D. Crommelin, T. Anchordoquy, D. Volkin, W. Jiskoot, E. Mastrobattista (2020)
Addressing the Cold Reality of mRNA Vaccine StabilityJournal of Pharmaceutical Sciences, 110
(1990)
10.1016/0264-410X(90)90091-YVaccine, 8
K. Khatri, A. Goyal, Prem Gupta, N. Mishra, S. Vyas (2008)
Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.International journal of pharmaceutics, 354 1-2
(1996)
10.1093/infdis/174.Supplement_3.S259J. Infect. Dis., 174
Sihan Guo, Dongwei Fu, Assem Utupova, Dejun Sun, Mo Zhou, Zheng Jin, Kai Zhao (2019)
Applications of polymer-based nanoparticles in vaccine fieldNanotechnology Reviews, 8
(2016)
10.1039/C6RA14419ERSC Adv., 6
(1990)
10.1016/0168-8278(90)90216-EJ. Hepatol., 11
M. Mohaghegh, M. Tafaghodi (2011)
Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbitPharmaceutical Development and Technology, 16
Yeu‐Chun Kim, F. Quan, R. Compans, Sang-Moo Kang, M. Prausnitz (2010)
Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.Journal of controlled release : official journal of the Controlled Release Society, 142 2
(World Health Organization. Projections of Mortality and Causes of Death, 2016 to 2060.)
World Health Organization. Projections of Mortality and Causes of Death, 2016 to 2060.World Health Organization. Projections of Mortality and Causes of Death, 2016 to 2060., World Health Organization. Projections of Mortality and Causes of Death, 2016 to 2060.
R. Verheul, B. Slütter, S. Bal, J. Bouwstra, W. Jiskoot, W. Hennink (2011)
Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination.Journal of controlled release : official journal of the Controlled Release Society, 156 1
R. Dobbelaer, M. Pfleiderer, M. Haase, E. Griffiths, I. Knezevic, A. Merkle, Y. Hongzhang, U. Candrian, M. Castillo, D. Wood, J. Daviaud, N. Dellepiane, Clara Hernández, S. Lambert, J. Shin, J. Fournier-Caruna, S. Kopp, T. Zhou, M. Zaffran, T. Bektimirov, G. Cooper, S. Silveira, W. Egan, N. Medveczky, T. Morris, Y. Núñez, Y. Horiuchi, T. Jivapaisarnpong, P. Krause, J. Martin, J. Southern, A. Utami, S. Jadhav, I. Susanti, I. Yamaguchi, M. Duchêne, A. Laschi, T. Schofield (2009)
Guidelines on stability evaluation of vaccines.Biologicals : journal of the International Association of Biological Standardization, 37 6
E. Pollard (1954)
The physics of viruses
F. Quan, Yeu‐Chun Kim, Dae-goon Yoo, R. Compans, M. Prausnitz, Sang-Moo Kang (2009)
Stabilization of Influenza Vaccine Enhances Protection by Microneedle Delivery in the Mouse SkinPLoS ONE, 4
Alexander Flood, Marcus Estrada, D. McAdams, Yuhua Ji, Dexiang Chen (2016)
Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine FormulationPLoS ONE, 11
(1997)
10.1016/S0264-410X(96)00170-3Vaccine, 15
(1999)
10.1016/S0264-410X(98)00363-6Vaccine, 17
Signe Schmidt, C. Foged, Karen Korsholm, T. Rades, D. Christensen (2016)
Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and ImmunostimulatorsPharmaceutics, 8
(A. Lynch, A. E. Meyers, A.-L. Williamson, and E. P. Rybicki, Virol. J., 9, (2012).)
A. Lynch, A. E. Meyers, A.-L. Williamson, and E. P. Rybicki, Virol. J., 9, (2012).A. Lynch, A. E. Meyers, A.-L. Williamson, and E. P. Rybicki, Virol. J., 9, (2012)., A. Lynch, A. E. Meyers, A.-L. Williamson, and E. P. Rybicki, Virol. J., 9, (2012).
Lei Xing, Yatong Fan, Tian-Jiao Zhou, Jia-Hui Gong, Lianhua Cui, Ki-Hyun Cho, Yun-Jaie Choi, Hu‐Lin Jiang, C. Cho (2018)
Chemical Modification of Chitosan for Efficient Vaccine DeliveryMolecules : A Journal of Synthetic Chemistry and Natural Product Chemistry, 23
Y. Ghendon, S. Markushin, Y. Vasiliev, I. Akopova, I. Koptiaeva, G. Krivtsov, O. Borisova, N. Ahmatova, E. Kurbatova, S. Mazurina, V. Gervazieva (2009)
Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterallyJournal of Medical Virology, 81
D. Bolen, I. Baskakov (2001)
The osmophobic effect: natural selection of a thermodynamic force in protein folding.Journal of molecular biology, 310 5
H. Štorkánová, S. Oreská, M. Špiritović, B. Heřmánková, K. Bubová, M. Komarc, K. Pavelka, J. Vencovský, J. Distler, L. Šenolt, R. Bečvář, M. Tomčík (2021)
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal studyScientific Reports, 11
G. Mogoșanu, A. Grumezescu, C. Bejenaru, L. Bejenaru (2016)
Polymeric protective agents for nanoparticles in drug delivery and targeting.International journal of pharmaceutics, 510 2
T. Kumar, M. Yadav, L. Singh (2016)
Role of Osmolytes in Regulating Immune System.Current pharmaceutical design, 22 20
E C Pollard (1953)
10.5962/bhl.title.10187The Physics of Viruses
Tauheed Hasan, K. Kumari, Sagolsem Devi, Jaya Handa, Tabish Rehman, N. Ansari, L. Singh (2018)
Osmolytes in vaccine production, flocculation and storage: a critical reviewHuman Vaccines & Immunotherapeutics, 15
(2001)
10.1016/S0264-410X(01)00140-2Vaccine, 19
Sunny Kumar, H. Tummala (2013)
Development of soluble inulin microparticles as a potent and safe vaccine adjuvant and delivery system.Molecular pharmaceutics, 10 5
Y. Perrie, Afzal Mohammed, Daniel Kirby, S. McNeil, Vincent Bramwell (2008)
Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.International journal of pharmaceutics, 364 2
(1999)
10.1023/A:1018820507379Pharm. Res., 16
P. Rigby (1969)
Prolongation of Survival of Tumour-bearing Animals by Transfer of “Immune” RNA with DEAE DextranNature, 221
J. Greenland, N. Letvin (2007)
Chemical adjuvants for plasmid DNA vaccines.Vaccine, 25 19
(2007)
10.1016/j.vaccine.2007.10.035Vaccine, 25
Vinay Saluja, Jean‐Pierre Amorij, J. Kapteyn, de Boer, H. Frijlink, W. Hinrichs (2010)
A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation.Journal of controlled release : official journal of the Controlled Release Society, 144 2
K. Masihi, W. Lange, W. Brehmer, E. Ribi (1986)
Immunobiological activities of nontoxic lipid A: enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects.International journal of immunopharmacology, 8 3
K. Schully, M. Bell, A. Prouty, M. Gallovic, S. Gautam, K. Peine, S. Sharma, E. Bachelder, J. Pesce, M. Elberson, K. Ainslie, A. Keane-Myers (2015)
Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis.International journal of pharmaceutics, 495 2
G. Leroux-Roels (2010)
Unmet needs in modern vaccinology: adjuvants to improve the immune response.Vaccine, 28 Suppl 3
H. Nosrati, Reza Khouy, A. Nosrati, M. Khodaei, Mehdi Banitalebi-Dehkordi, Korosh Ashrafi-Dehkordi, Samira Sanami, Z. Alizadeh (2021)
Nanocomposite scaffolds for accelerating chronic wound healing by enhancing angiogenesisJournal of Nanobiotechnology, 19
P. Moyle (2017)
Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines.Biotechnology advances, 35 3
K. Maaden, E. Sekerdag, P. Schipper, G. Kersten, W. Jiskoot, J. Bouwstra (2015)
Layer-by-Layer Assembly of Inactivated Poliovirus and N-Trimethyl Chitosan on pH-Sensitive Microneedles for Dermal Vaccination.Langmuir : the ACS journal of surfaces and colloids, 31 31
Lihua Ma, Changsheng Liu (2010)
Preparation of chitosan microspheres by ionotropic gelation under a high voltage electrostatic field for protein delivery.Colloids and surfaces. B, Biointerfaces, 75 2
Sandra Robla, M. Prasanna, R. Varela-Calviño, C. Grandjean, N. Csaba (2021)
A chitosan-based nanosystem as pneumococcal vaccine delivery platformDrug Delivery and Translational Research, 11
P. Cooper, N. Petrovsky (2011)
Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers.Glycobiology, 21 5
K. Ferrell, Erica Stewart, C. Counoupas, T. Ashhurst, W. Britton, N. Petrovsky, J. Triccas (2021)
Intrapulmonary vaccination with delta-inulin adjuvant stimulates non-polarised chemotactic signalling and diverse cellular interactionMucosal Immunology, 14
(2018)
10.2147/IJN.S165876IJN, 13
P. Cooper, E. Steele (1988)
The adjuvanticity of gamma inulinImmunology and Cell Biology, 66
‘New-Gen Vaccines’ are grabbing the attention of scientists as they are much suitable for an immune-compromised group of individuals as well as infants. The major drawbacks of these vaccines are lower immunogenicity and instability. The need for a convenient and safe adjuvant is still under exploration. On the other hand, thermal instability leads to the inactivation of the vaccine and becomes detrimental in many cases. Thus, there is a need to incorporate new kinds of excipients into vaccine formulation to enhance the potency/immunogenicity of vaccine antigens and also act as stabilizers. A limited or single excipient in providing the required dual-activity is vital to break the stereotypical usage of the well-entrenched adverse ingredients. In the proposed review, the efficiency of naturally occurring biocompatible carbohydrate polymers and osmolytes and their ‘dual-role’ is briefed. In addition, the information on the possible mechanisms of action of carbohydrate polymers in vaccines as adjuvants and stabilizers are also discussed.[graphic not available: see fulltext]
Macromolecular Research – Springer Journals
Published: Sep 1, 2022
Keywords: bio-molecules; carbohydrate polymers; osmolytes; mechanism of action; new-gen vaccines; vaccine excipients
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.